Tonix Pharmaceuticals Holding Corp. (TNXP) is a publicly traded Healthcare sector company. As of May 21, 2026, TNXP trades at $14.21 with a market cap of $227.32M and a P/E ratio of -0.99. TNXP moved +5.47% today. Year to date, TNXP is -4.73%; over the trailing twelve months it is -51.51%. Its 52-week range spans $6.76 to $130.00. Analyst consensus is strong buy with an average price target of $41.33. Rallies surfaces TNXP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for TNXP combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $14.21 |
| Market Cap | $227.32M |
| P/E Ratio | -0.99 |
| EPS | $-14.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $130.00 |
| 52-Week Low | $6.76 |
| Volume | 339 |
| Avg Volume | 0 |
| Revenue (TTM) | $17.56M |
| Net Income | $-147.39M |
| Gross Margin | 58.56% |
3 analysts cover TNXP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.33.